SOURCE: Cambridge Healthtech Institute

July 17, 2007 11:00 ET

The Latest Advances in Biodefense and Point-of-Care Diagnostics to Be Discussed at CHI's Co-Located Conferences on August 13-15, 2007 at the Ritz-Carlton Hotel, Washington, D.C.

NEEDHAM, MA--(Marketwire - July 17, 2007) - Cambridge Healthtech Institute, a premier information provider for the life sciences industry, will hold two co-located conferences next month: Sixth Annual Systems Integration in Biodefense (August 13-14) and Inaugural Enabling Point-of-Care Diagnostics (August 14-15) at the Ritz-Carlton Hotel, Washington, D.C.

"Over the past five years, Cambridge Healthtech Institute has attracted 900+ researchers to its Biodefense conference. Since national security is so important now in a post-9/11 world, CHI is proud to take the lead on organizing an annual forum where government, industry and academic researchers can learn from each other on bioterrorism," states Christina Lingham, Conference Director, Cambridge Healthtech Institute. According to Lingham, "I am pleased that we extended our programming options for Biodefense delegates to participate in more sessions and be able to attend a shared session at our co-located Enabling Point-of-Care Diagnostics conference."

During the Biodefense conference on August 13-14, delegates will be able to follow speeches from experts, such as John Vitko, Jr., Ph.D., the director of the chemical and biological defense division at the department of homeland security, who will address a presentation on challenges in developing & deploying new detection technologies; and Mr. Jean D. Reed, the special assistant to the secretary of defense for chemical and biological defense and chemical demilitarization programs, will discuss the department of defense chemical biological defense program (CBDP).

Besides these two presentations, the Biodefense conference will offer a unique learning experience centering on:

--  Implementing Technologies in Real World Settings
--  Real Time Detection and Protection
--  Advancements in Rapid Biodefense Countermeasures
--  From Mechanism of Action to a Next Generation Vaccine
--  Bridging Biodefense and Clinical Applications
    

Bridging biodefense and clinical application kicks off the first day of CHI's Inaugural Enabling Point-of-Care Diagnostics Conference on August 14. On day two of the Diagnostics conference, presentations on integrating point-of-care devices in clinical practice for pathogen detection and rapid screening will be discussed.

For up-to-date infrormation on CHI's Sixth Annual Systems Integration in Biodefense, visit www.healthtech.com/2007/BTR.

For up-to-date information on CHI's Inaugural Enabling Point-of-Care Diagnostics, visit www.healthtech.com/2007/POC.

Members of the press are invited to attend both conferences. To obtain a press pass, contact Tracey Fielding at (781) 972-5429 or tfielding@healthtech.com.

To become a sponsor or exhibitor, please contact David Karp at (781) 972-5483 or dkarp@healthtech.com.

Cambridge Healthtech Institute

Cambridge Healthtech Institute is dedicated to producing conferences that service the life science community. Our conferences provide valuable new insights and competing points of view on the very latest developments within the pharmaceutical and biomedical industry. Each year, CHI holds 100 conferences that bring together leaders from their respective discipline. In the past 14 years, CHI has produced over 400 conferences, attracting more than 50,000 attendees from around the world. For more details, visit www.healthtech.com.

Contact Information

  • For more information:
    James Prudhomme
    Cambridge Healthtech Institute
    (781) 972-5486
    Email Contact